Evidence map›Paper›PMID 36479305›Full record

ArticleRisk management and healthcare policy2022

Understanding the Attitudes and Willingness of Adult Chinese Patients with Rheumatic Diseases Towards COVID-19 Vaccination.

Huiqiong Zeng, Hanjiang Liu, Meifen Liu, Zhen Zhou, Shi-Bin Wang, Kaixia Zhou, Wengen Li, Liping Dai, Yashuo Chen, John Patrick Uy and 2 more

Open access · goldAbstract read
In one paragraph

Article in Risk management and healthcare policy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 4 countries.

Huiqiong Zeng *Department of Rheumatology, Shenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, People's Republic of China.
Hanjiang Liu *Department of Safety Supervision Division, Guangdong Pharmaceutical Association, Guangzhou, People's Republic of China.
Meifen LiuDepartment of Rheumatology, Shenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, People's Republic of China.
Zhen ZhouDepartment of Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
Shi-Bin WangDepartment of Mental Health, Guangdong Mental Health Center, Guangdong Provincial People's Hospital, Guangzhou, People's Republic of China.
Kaixia ZhouDepartment of Clinical Laboratory, Shanghai Cancer Center, Fudan University, Shanghai, People's Republic of China.
Wengen LiDepartment of Rheumatology and Immunology, Meizhou People's Hospital (Huangtang Hospital), Meizhou, People's Republic of China.
Liping DaiDepartment of Rheumatology, Shenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, People's Republic of China.
Yashuo ChenDepartment of Rheumatology, Shenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, People's Republic of China.
John Patrick UyDepartment of Infectious Disease and International Health, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Chenyu SunDepartment of AMITA Health Saint Joseph Hospital Chicago, University of Illinois at Chicago, Chicago, IL, USA.ORCID 0000-0003-3812-3164
Zhizhong YeDepartment of Rheumatology, Shenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, People's Republic of China.ORCID 0000-0002-2480-6004
ShenZhen People’s Hospital · CNDartmouth–Hitchcock Medical Center · USFudan University Shanghai Cancer Center · CNGuangdong Pharmaceutical University · CNGuangdong Provincial People's Hospital · CNMeizhou City People's Hospital · CNUniversity of Illinois Chicago · USUniversity of Tasmania · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The SARS-CoV-2 pandemic has imposed substantial health and economic burdens on the societies. COVID-19 vaccination is the most effective method of controlling the epidemic. This study assessed the attitude, willingness, and related factors of adult patients with rheumatic diseases (RDs) in China towards COVID-19 vaccination and identified their reasons for being vaccinated. Methods: A cross-sectional survey was administered to patients with rheumatic diseases from July 18 to August 18, 2021, using an online questionnaire. Logistic regression analysis was performed to examine the data. Results: We analyzed data drawn from 464 participants who provided valid responses. A total of 324 (69.83%) RD patients were not willing to be vaccinated, of which 76.97% believed that COVID-19 vaccination might exacerbate the diseases symptoms. Logistic regression analysis showed that a combination of experiencing systemic damage, being in the acute attack stage of the disease, and fear of the adverse impact of vaccination on rheumatism, etc., were the predominant factors affecting the intentional vaccination rate in adult patients with rheumatic diseases ( Conclusion: The COVID-19 intentional vaccination rate was relatively low in adult Chinese patients with RD. Public health education and the dissemination of government scientific data for patients with RD should be enhanced to increase COVID-19 vaccination rates.

Indexed as

attitudeChinaCOVID-19rheumatic diseasevaccinationwillingness

Identifiers

PMID36479305
PMCPMC9721124
OpenAlexW4310416829

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.